Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00921011 · ClinicalTrials.gov registry record
Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 177
- Enrollment target
NCT00921011: Completed study, sponsored by Ohio State University.
NCT00921011 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00921011 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis. This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if there is a correlation between iron accumulation and hardening of the arteries. In addition, blood levels of hormones will be measured to help show differences due to hormone levels vs. iron accumulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2009-05 |
| Est. Completion | 2018-03 |
What the finished NCT00921011 record still lists
NCT00921011 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00921011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00921011 about?
NCT00921011 is a clinical study titled "Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis". The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis. This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if ...
What is the current status of trial NCT00921011?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2009-05. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT00921011?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia